{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mr+Jim+Cunningham&AnsweringBody.=Department+of+Health&answer.dateOfAnswer=2015-11-30&min-answer.questionFirstAnswered.=2014-11-03T17%3A21%3A31.7181985Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Mr+Jim+Cunningham&AnsweringBody.=Department+of+Health&answer.dateOfAnswer=2015-11-30&min-answer.questionFirstAnswered.=2014-11-03T17%3A21%3A31.7181985Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mr+Jim+Cunningham&AnsweringBody.=Department+of+Health&answer.dateOfAnswer=2015-11-30&min-answer.questionFirstAnswered.=2014-11-03T17%3A21%3A31.7181985Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mr+Jim+Cunningham&_page=0&AnsweringBody.=Department+of+Health&answer.dateOfAnswer=2015-11-30&min-answer.questionFirstAnswered.=2014-11-03T17%3A21%3A31.7181985Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mr+Jim+Cunningham&AnsweringBody.=Department+of+Health&answer.dateOfAnswer=2015-11-30&min-answer.questionFirstAnswered.=2014-11-03T17%3A21%3A31.7181985Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Mr+Jim+Cunningham&AnsweringBody.=Department+of+Health&answer.dateOfAnswer=2015-11-30&min-answer.questionFirstAnswered.=2014-11-03T17%3A21%3A31.7181985Z", "items" : [{"_about" : "http://data.parliament.uk/resources/431995", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/431995/answer", "answerText" : {"_value" : "

<\/strong><\/p>

The UK Five Year Antimicrobial Resistance Strategy (AMR) Strategy detailed implementation plan, published in December 2014, set out those activities that needed to be undertaken to deliver the strategy in each of seven key areas for action. No separate budget was identified. Activity in the plan is led by the Department of Health, Public Health England, Department for Environment, Food and Rural Affairs and NHS England and is incorporated within existing business plans for those organisations.<\/p>

In March 2015 the Government announced the new £195 million Fleming Fund to strengthen surveillance of drug resistance and laboratory capacity in developing countries. As stated in the Overseas Development Aid Strategy, published on 22 November. The Government will invest a further £70 million in the Fleming Fund and deliver the new Global AMR Innovation Fund launched with China. The Government will continue to push for further international financing for research and innovation to tackle AMR.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-11-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-11-30T17:20:20.48Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-11-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what the budget is for implementation of the UK Five Year Antimicrobial Resistance Strategy; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"} } , "tablingMemberConstituency" : {"_value" : "Coventry South"} , "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"} ], "uin" : "17474"} , {"_about" : "http://data.parliament.uk/resources/432004", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/432004/answer", "answerText" : {"_value" : "

Public Health England (PHE) has surveillance data on meticillin resistant Staphylococcus aureus<\/em> (MRSA) bacteraemia, E. coli<\/em> bacteraemia and on C. difficile<\/em> Infection (CDI). The reported numbers for both MRSA and E. <\/em>coli bacteraemia cover bloodstream infections only. C. difficile<\/em> data covers all infections. The totals, shown in the table below, are the number of infections reported to PHE each financial year, extracted from the Healthcare Associated Infections (HCAI) data capture system. Mandatory surveillance data covers England only.<\/p>

Total Number of MRSA, C. difficile<\/em> and E. coli<\/em> infections in England (April 2010 to March 2015)<\/p>

Year:<\/p><\/td>

April 2010 - March 2011<\/p><\/td>

April 2011 - March 2012<\/p><\/td>

April 2012 - March 2013<\/p><\/td>

April 2013- March 2014<\/p><\/td>

April 2014 - March 2015<\/p><\/td><\/tr>

Total reported MRSA bacteraemia episodes<\/p><\/td>

1,481<\/p><\/td>

1,116<\/p><\/td>

924<\/p><\/td>

862<\/p><\/td>

801<\/p><\/td><\/tr>

Total reported C. difficile <\/em>episodes<\/p><\/td>

21,707<\/p><\/td>

18,022<\/p><\/td>

14,694<\/p><\/td>

13,361<\/p><\/td>

14,165<\/p><\/td><\/tr>

Total reported E. coli<\/em> bacteraemia episodes<\/p><\/td>


*<\/p><\/td>


*<\/p><\/td>

32,309<\/p><\/td>

34,275<\/p><\/td>

35,676<\/p><\/td><\/tr><\/tbody><\/table>

* Mandatory surveillance of E. coli<\/em> bacteraemia was introduced in July 2011.<\/p>

Source:<\/em> PHE.<\/p>

<\/strong><\/p>

<\/strong><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3988", "label" : {"_value" : "Biography information for Ben Gummer"} } , "answeringMemberConstituency" : {"_value" : "Ipswich"} , "answeringMemberPrinted" : {"_value" : "Ben Gummer"} , "dateOfAnswer" : {"_value" : "2015-11-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-11-30T17:04:10.57Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-11-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Antibiotics: Drug Resistance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 24 November 2015 to Question 17021, what the number of methicillin resistant (a) staphylococcus aureus, (b) clostridium difficile and (c) E.coli infections were in England and Wales in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"} } , "tablingMemberConstituency" : {"_value" : "Coventry South"} , "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"} ], "uin" : "17535"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }